JUN 28, 2017 10:30 AM PDT

WEBINAR: Variant detection in cell-free DNA from NSCLC using NGS

Speaker
  • Associate Professor, Princess Margaret Cancer Centre
    Biography
      Dr. Stockley is a clinical molecular geneticist and Associate Director of the Molecular Diagnostics Division at the University Health Network, providing leadership within the two divisional molecular diagnostic laboratories. She is a member of the Board of Directors of the Canadian College of Medical Geneticists, the Canadian representative to the International Organization for Standardization Working Group on Molecular Diagnostics, and a member of the Laboratory Accrediation Advisory Panel for the Institute for Quality Management in Healthcare. Dr. Stockley's interests include the development of novel molecular diagnostic testing using high-throughput methodologies, and implementation and evaluation of genetic and genomic tests, particularly for acquired and inherited cancers.

    Abstract

    DATE: June 28, 2017
    TIME: 10:30am PT, 1:30pm ET

    This webinar will describe the implementation of the Oncomine Lung cfDNA Assay from Thermo Fisher Scientific in the Advanced Molecular Diagnostic Laboratory at the Princess Margaret Cancer Centre in Toronto, Canada.  Dr. Stockley will describe the Princess Margaret experience using the Oncomine Lung cfDNA assay for detection of variants in circulating cell-free DNA from non-small cell lung cancer (NSCLC) samples.  The usefulness of detection of the EGFR T790M resistance mutation in cell-free DNA, and comparison to EGFR T790M detection by droplet digital PCR (ddPCR), will also be presented. 

    Learning objectives:

    • Understand the utility of the Oncomine Lung cfDNA for testing of cell-free DNA for NSCLC
    • Describe the advantages of using the Oncomine Lung cfDNA for detection of the EGFR T790M resistance mutation as compared to droplet digital PCR (ddPCR

    For RUO.  Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    MAR 31, 2020 9:00 AM PDT
    C.E. CREDITS
    MAR 31, 2020 9:00 AM PDT
    DATE: March 31, 2020 TIME: 9:00am PT, 12:00pm ET HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2...
    Loading Comments...
    Show Resources